US smokers need photo ID to prove new age limit set by the FDA
The US drug regulator raised the age limit of people who want to buy tobacco products by three years to 30, and retailers.
Drugs
Health
Pharma
Drugs
Health
Pharma
Regulator okays Insulet’s insulin pump in US to treat type 2 diabetes
Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients.
Drugs
Health
Pharma
US drug regulator blocks Regeneron’s blood cancer therapy
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Drugs
Health
Pharma
US-based ARS’s nasal spray to treat allergic reactions gets FDA nod
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.
Drugs
Health
Pharma
US regulator rejects Lykos’s MDMA therapy, wants more data
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.
Drugs
Health
Pharma
Purdue Pharma’s opioid overdose drug gets US regulator’s nod
US drugmaker Purdue Pharma’s injection to treat opioid overdose in adults and patients 12 years or older, got the country’s drug regulator’s approval.
Drugs
Health
Pharma
Novartis’s drug to treat rare kidney disease gets USFDA approval
Switzerland’s Novartis AG has received accelerated approval from the USFDA for its drug to reduce elevated levels of proteins in the urine of.
Drugs
Health
Pharma
US regulator allows GSK’s endometrial cancer therapy for expanded use
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.
Drugs
Health
Pharma
Adaptimmune’s therapy to treat rare form of cancer gets USFDA nod
UK-based biopharmaceutical company, Adaptimmune Therapeutics Plc, got FDA approval for its cell therapy for treating a rare form of cancer.
Drugs
Health
Pharma
Eli Lilly’s trial weight-loss drug reduces heart failure risk by 38%
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.